Skip to main content
Erschienen in: Current Cardiology Reports 1/2010

01.01.2010

Primary Intracranial Stenting in Acute Ischemic Stroke

verfasst von: Gregory J. Velat, Brian L. Hoh, Elad I. Levy, J Mocco

Erschienen in: Current Cardiology Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Acute intracranial stroke is a major source of morbidity and mortality in the United States. Recent studies have shown improved clinical outcomes for patients who achieve timely arterial recanalization. Multimodal therapies have evolved to meet this end point and include intravenous and/or intra-arterial thrombolysis and mechanical thrombolysis. Modifications to existing balloon-mounted stents commonly used in cardiology have yielded more easily navigable and safer self-expanding intracranial stents that provide rapid arterial recanalization. We review the evolution of acute stroke therapy over the past few decades and the recent results of mechanical thrombolysis, focusing on intracranial stenting in the setting of acute stroke.
Literatur
1.
Zurück zum Zitat Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480–486.CrossRefPubMed Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480–486.CrossRefPubMed
2.
Zurück zum Zitat Gobin YP, Starkman S, Duckwiler GR, et al.: MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004, 35:2848–2854.CrossRefPubMed Gobin YP, Starkman S, Duckwiler GR, et al.: MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004, 35:2848–2854.CrossRefPubMed
3.
Zurück zum Zitat • Hacke W, Kaste M, Bluhmki E, et al.: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317–1329. This is a retrospective multicenter study illustrating the safety of IV rt-PA administered between 3 and 4.5 hours following stroke onset without significant differences in outcome measures or complications.CrossRefPubMed • Hacke W, Kaste M, Bluhmki E, et al.: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317–1329. This is a retrospective multicenter study illustrating the safety of IV rt-PA administered between 3 and 4.5 hours following stroke onset without significant differences in outcome measures or complications.CrossRefPubMed
4.
Zurück zum Zitat Hacke W, Kaste M, Fieschi C, et al.: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017–1025.CrossRefPubMed Hacke W, Kaste M, Fieschi C, et al.: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017–1025.CrossRefPubMed
5.
Zurück zum Zitat Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245–1251.CrossRefPubMed Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245–1251.CrossRefPubMed
6.
Zurück zum Zitat Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007, 38:967–973.CrossRefPubMed Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007, 38:967–973.CrossRefPubMed
7.
Zurück zum Zitat Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432–1438.CrossRefPubMed Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432–1438.CrossRefPubMed
8.
Zurück zum Zitat Zaidat OO, Suarez JI, Sunshine JL, et al.: Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005, 26:880–884.PubMed Zaidat OO, Suarez JI, Sunshine JL, et al.: Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005, 26:880–884.PubMed
9.
Zurück zum Zitat Barber PA, Zhang J, Demchuk AM, et al: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001, 56:1015–1020.PubMed Barber PA, Zhang J, Demchuk AM, et al: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001, 56:1015–1020.PubMed
10.
Zurück zum Zitat The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [no authors listed]. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587.CrossRef The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [no authors listed]. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587.CrossRef
11.
Zurück zum Zitat Wolpert SM, Bruckmann H, Greenlee R, et al.: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993, 14:3–13.PubMed Wolpert SM, Bruckmann H, Greenlee R, et al.: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993, 14:3–13.PubMed
12.
Zurück zum Zitat Saqqur M, Uchino K, Demchuk AM, et al.: Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007, 38:948–954.CrossRefPubMed Saqqur M, Uchino K, Demchuk AM, et al.: Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007, 38:948–954.CrossRefPubMed
13.
Zurück zum Zitat Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002, 59:862–867.CrossRefPubMed Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002, 59:862–867.CrossRefPubMed
14.
Zurück zum Zitat Janjua N, Alkawi A, Suri MF, Qureshi AI: Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 2008, 29:253–258.CrossRefPubMed Janjua N, Alkawi A, Suri MF, Qureshi AI: Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 2008, 29:253–258.CrossRefPubMed
15.
Zurück zum Zitat Saqqur M, Molina CA, Salam A, et al.: Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007, 38:69–74.CrossRefPubMed Saqqur M, Molina CA, Salam A, et al.: Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007, 38:69–74.CrossRefPubMed
16.
Zurück zum Zitat Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003–2011.CrossRefPubMed Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003–2011.CrossRefPubMed
17.
Zurück zum Zitat Tomsick T, Broderick J, Carrozella J, et al.: Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008, 29:582–587.CrossRefPubMed Tomsick T, Broderick J, Carrozella J, et al.: Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008, 29:582–587.CrossRefPubMed
18.
Zurück zum Zitat • Smith WS, Sung G, Saver J, et al.: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008, 39:1205–1212. This is a prospective, multicenter study detailing significant recanalization rates in patients treated with the MERCI device in combination with other adjunctive thrombolytic therapies.CrossRefPubMed • Smith WS, Sung G, Saver J, et al.: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008, 39:1205–1212. This is a prospective, multicenter study detailing significant recanalization rates in patients treated with the MERCI device in combination with other adjunctive thrombolytic therapies.CrossRefPubMed
19.
Zurück zum Zitat Bose A, Henkes H, Alfke K, et al.: The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008, 29:1409–1413.CrossRefPubMed Bose A, Henkes H, Alfke K, et al.: The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008, 29:1409–1413.CrossRefPubMed
20.
Zurück zum Zitat • Penumbra Pivotal Stroke Trial Investigators: The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009, 40:2761–2768. This is a prospective, multicenter trial showing moderate arterial recanalization rates for patients treated within 8 hours of acute stroke onset. There was a concerning incidence of hemorrhagic complications in this study.CrossRef • Penumbra Pivotal Stroke Trial Investigators: The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009, 40:2761–2768. This is a prospective, multicenter trial showing moderate arterial recanalization rates for patients treated within 8 hours of acute stroke onset. There was a concerning incidence of hemorrhagic complications in this study.CrossRef
21.
Zurück zum Zitat Levy EI, Ecker RD, Horowitz MB, et al.: Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006, 58:458–463.PubMed Levy EI, Ecker RD, Horowitz MB, et al.: Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006, 58:458–463.PubMed
22.
Zurück zum Zitat Lee VH, Samuels S, Herbst TJ, et al.: Histopathologic description of wingspan stent in acute ischemic stroke. Neurocrit Care 2009 Aug 5 (Epub ahead of print). Lee VH, Samuels S, Herbst TJ, et al.: Histopathologic description of wingspan stent in acute ischemic stroke. Neurocrit Care 2009 Aug 5 (Epub ahead of print).
23.
Zurück zum Zitat Levy EI, Chaturvedi S: Perforator stroke following intracranial stenting: a sacrifice for the greater good? Neurology 2006, 66:1803–1804.CrossRefPubMed Levy EI, Chaturvedi S: Perforator stroke following intracranial stenting: a sacrifice for the greater good? Neurology 2006, 66:1803–1804.CrossRefPubMed
24.
Zurück zum Zitat Levy EI, Sauvageau E, Hanel RA, et al.: Self-expanding versus balloon-mounted stents for vessel recanalization following embolic occlusion in the canine model: technical feasibility study. AJNR Am J Neuroradiol 2006, 27:2069–2072.PubMed Levy EI, Sauvageau E, Hanel RA, et al.: Self-expanding versus balloon-mounted stents for vessel recanalization following embolic occlusion in the canine model: technical feasibility study. AJNR Am J Neuroradiol 2006, 27:2069–2072.PubMed
25.
Zurück zum Zitat Fitzsimmons BF, Becske T, Nelson PK: Rapid stent-supported revascularization in acute ischemic stroke. AJNR Am J Neuroradiol 2006, 27:1132–1134. PubMed Fitzsimmons BF, Becske T, Nelson PK: Rapid stent-supported revascularization in acute ischemic stroke. AJNR Am J Neuroradiol 2006, 27:1132–1134. PubMed
26.
Zurück zum Zitat Sauvageau E, Levy EI: Self-expanding stent-assisted middle cerebral artery recanalization: technical note. Neuroradiology 2006, 48:405–408.CrossRefPubMed Sauvageau E, Levy EI: Self-expanding stent-assisted middle cerebral artery recanalization: technical note. Neuroradiology 2006, 48:405–408.CrossRefPubMed
27.
Zurück zum Zitat •• Levy EI, Mehta R, Gupta R, et al.: Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007, 28:816–822. This is an excellent multicenter retrospective review of intracranial stenting for acute stroke.PubMed •• Levy EI, Mehta R, Gupta R, et al.: Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007, 28:816–822. This is an excellent multicenter retrospective review of intracranial stenting for acute stroke.PubMed
28.
Zurück zum Zitat • Zaidat OO, Wolfe T, Hussain SI, et al.: Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008, 39:2392–2395. This is a retrospective single-center case series detailing successful deployment of intracranial stents as rescue therapy in the setting of acute stroke.CrossRefPubMed • Zaidat OO, Wolfe T, Hussain SI, et al.: Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008, 39:2392–2395. This is a retrospective single-center case series detailing successful deployment of intracranial stents as rescue therapy in the setting of acute stroke.CrossRefPubMed
29.
Zurück zum Zitat •• Brekenfeld C, Schroth G, Mattle HP, et al.: Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009, 40:847–852. This is a retrospective single-center case series illustrating the efficacy on intracranial stenting as rescue therapy in the setting of acute stroke.CrossRefPubMed •• Brekenfeld C, Schroth G, Mattle HP, et al.: Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009, 40:847–852. This is a retrospective single-center case series illustrating the efficacy on intracranial stenting as rescue therapy in the setting of acute stroke.CrossRefPubMed
30.
Zurück zum Zitat •• Levy EI, Siddiqui AH, Crumlish A, et al.: First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke. SARIS (Stent-Assisted Recanalization in Acute Ischemic Stroke). Stroke 2009 Aug 21 (Epub ahead of print). This represents the first FDA-approved prospective study showing significant clinical benefit in adult patients who underwent intracranial stenting as salvage therapy. •• Levy EI, Siddiqui AH, Crumlish A, et al.: First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke. SARIS (Stent-Assisted Recanalization in Acute Ischemic Stroke). Stroke 2009 Aug 21 (Epub ahead of print). This represents the first FDA-approved prospective study showing significant clinical benefit in adult patients who underwent intracranial stenting as salvage therapy.
31.
Zurück zum Zitat • Kelly ME, Furlan AJ, Fiorella D: Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 2008, 39:1770–1773. This is the first published case report of a temporary endovascular bypass using an intracranial stent.CrossRefPubMed • Kelly ME, Furlan AJ, Fiorella D: Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 2008, 39:1770–1773. This is the first published case report of a temporary endovascular bypass using an intracranial stent.CrossRefPubMed
32.
Zurück zum Zitat • Hauck EF, Mocco J, Snyder KV, Levy EI: Temporary endovascular bypass: a novel treatment for acute stroke. AJNR Am J Neuroradiol 2009, 30:1532–1533. This is the second published report of a temporary endovascular bypass using an intracranial stent.CrossRefPubMed • Hauck EF, Mocco J, Snyder KV, Levy EI: Temporary endovascular bypass: a novel treatment for acute stroke. AJNR Am J Neuroradiol 2009, 30:1532–1533. This is the second published report of a temporary endovascular bypass using an intracranial stent.CrossRefPubMed
Metadaten
Titel
Primary Intracranial Stenting in Acute Ischemic Stroke
verfasst von
Gregory J. Velat
Brian L. Hoh
Elad I. Levy
J Mocco
Publikationsdatum
01.01.2010
Verlag
Current Science Inc.
Erschienen in
Current Cardiology Reports / Ausgabe 1/2010
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-009-0069-x

Weitere Artikel der Ausgabe 1/2010

Current Cardiology Reports 1/2010 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.